WuXi AppTec Co., Ltd. (SHA:603259)
139.00
-3.01 (-2.12%)
Nov 2, 2026, 11:30 AM CST
WuXi AppTec Revenue
WuXi AppTec had revenue of 16.64B CNY in the quarter ending September 30, 2026, with 38.01% growth. This brings the company's total for the last twelve months to 56.10B, up 33.14% year-over-year. In the year 2025, WuXi AppTec had annual revenue of 43.42B with 21.40% growth. That makes WuXi AppTec the 1,711th largest company in the world by revenue and 179th in China.
Revenue (ttm)
56.10B
Revenue Growth
+33.14%
P/S Ratio
7.57
Revenue / Employee
1.66M
Employees
35,584
Market Cap
415.41B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full WuXi AppTec breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 43.42B | 7.65B | 21.40% |
| Dec 31, 2024 | 35.77B | -2.91B | -7.53% |
| Dec 31, 2023 | 38.68B | -676.78M | -1.72% |
| Dec 31, 2022 | 39.35B | 16.45B | 71.84% |
| Dec 31, 2021 | 22.90B | 6.37B | 38.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 9.94B |
| Hangzhou Tigermed Consulting | 7.60B |
| Shanghai Runda Medical Technology | 6.52B |
| Guangzhou Kingmed Diagnostics Group | 5.89B |
| BGI Genomics | 3.72B |
| Maccura Biotechnology Co.Ltd | 2.18B |
| Joinn Laboratories(China)Co.,Ltd. | 1.86B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
WuXi AppTec News
- 6 days ago - WuXi AppTec Delivers Strong Q1-Q3 2026 Results and Further Raises Full-Year Guidance, Driven by Greater Success of Multiple Customers' Products and CRDMO Model - PRNewsWire
- 6 days ago - WuXi AppTec Quarterly report: Q3 2026 - Filings
- 6 days ago - WuXi AppTec Slides: Q3 2026 - Filings
- 13 days ago - WuXi AppTec Receives Frost & Sullivan's Global Company of the Year Recognition in CRDMO for Tenth Consecutive Year - PRNewsWire
- 25 days ago - WuXi AppTec Earns EcoVadis Gold Medal for Third Consecutive Year, Ranking Among Global Top 5% for Sustainability - PRNewsWire
- 2 months ago - WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion - PRNewsWire
- 2 months ago - Judge blocks US decision to add WuXi to list of firms tied to Chinese military - Reuters
- 3 months ago - WuXi AppTec Quarterly report: Q2 2026 - Filings